Horizon Pharma plc Responds to Express Scripts Lawsuit and Recent Allegations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Negative Press Doesn't Change UBS View on Horizon Pharma (HZNP)
November 12, 2015 9:14 AM ESTUBS analyst Marc Goodman, published a note on Horizon Pharma (NASDAQ: HZNP) in the wake of negative press:
Express Scripts (NASDAQ: ESRX) is suing Horizon for $140M of owed rebates under a contractual agreement that Horizon... More
Horizon Pharma (HZNP) Responds to Express Scripts' (ESRX) Lawsuit; Says Linden Care Isn't So-Called 'Captive Pharmacy'
November 11, 2015 6:42 AM ESTHorizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, responded to a lawsuit filed by Express Scripts (NASDAQ: ESRX) and recent allegations:
Our primary concern is for the patients who, based on the profit driven actions of Express Scripts, may be denied access to medicines that are prescribed by their physicians. We are committed to ensuring that regardless of these actions,... More
